Pharma News

Sildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability and delay clinical worsening.

A new study from Mass Eye and Ear investigators shows that individuals who report tinnitus, which present as a ringing in the ears in more than one out of ten adults worldwide, are experiencing auditory nerve loss that is not picked up by conventional hearing tests.

A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.

A prototype using The University of Queensland-developed and Vaxxas-commercialised high-density microarray patch (HD-MAP) has delivered a University of Adelaide-developed vaccine and elicited an effective immune response to Zika virus in mice.

Merck, a leading science and technology company, has announced the winners of Merck Young Scientist Award 2023, season-3 to recognise young scientists in India.

The Association of Advanced pharmacy practitioners (AAPP) strongly urges the government of India to change certain drafted rules of National pharmacy commission Bill. The recommendations of AAPP mainly focused on number of members in council, minimum qualification to registered as pharmacist and national level entrance examination to enter in pharmacy education.

The Pharmacy Council of India (PCI) will launch a revamped – DIGI-PHARMed application on December 1 with four integrated services having an objective to regulate the Pharmacy education in the country by enrollment/ registration of Pharmacy institutions/ Pharmacist/ Pharmacy student/ Pharmacist jobseeker across India.

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Ivabradine Tablets, 5 mg and 7.5 mg (USRLD: Corlanor® Tablets, 5 mg and 7.5 mg).

The COVID-19 pandemic demonstrated the importance of being prepared with drug interventions to contain viral outbreaks that can otherwise have devastating consequences. In preparing for the next pandemic—or Disease X, there is an urgent need for versatile platform technologies that could be repurposed upon short notice, to combat infectious outbreaks.

The ARIES-HM3 Randomized Clinical Trial assessed the safety and efficacy of excluding aspirin from the antithrombotic regimen in patients with advanced heart failure who have undergone implantation of a fully magnetically levitated left ventricular assist device (LVAD).